This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: The Innovations of Patrick Case
Introduction
Patrick Case is a notable inventor based in Bristol, GB. He has made significant contributions to the field of biotechnology, particularly in the development of treatments for various neurological conditions. His work focuses on the use of specific polynucleotides and polypeptides that have the potential to revolutionize therapeutic protocols.
Latest Patents
Patrick Case holds a patent for KIAA0551 polynucleotides and polypeptides. This patent outlines the use of KIAA0551 polypeptides and polynucleotides in designing protocols for treating neuropathies, neuropathic pain, inflammatory and chronic pain, and neurodegenerative conditions such as Motor Neuron Disease, Parkinson's Disease, Alzheimer's Disease, and other dementias. Additionally, it addresses ischaemic damage in neuronal and cardiac tissues caused by diseases or infectious agents. The patent also discloses methods for producing these polypeptides through recombinant techniques.
Career Highlights
Patrick Case is associated with SmithKline Beecham Corporation, where he has been instrumental in advancing research in his field. His innovative approach and dedication to improving patient outcomes have made him a respected figure in the biotechnology community.
Collaborations
Throughout his career, Patrick has collaborated with talented individuals such as Sharon Bingham and Oliver Lars Rausch. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of groundbreaking solutions.
Conclusion
Patrick Case's contributions to the field of biotechnology, particularly through his patent on KIAA0551 polynucleotides and polypeptides, highlight his commitment to addressing critical health challenges. His work continues to inspire advancements in the treatment of neurological conditions.